Why the study?
Does probucol prevent atrial remodeling and AF development in alloxan-induced diabetic rabbits?
Does probucol prevent atrial remodeling and AF development in alloxan-induced diabetic rabbits?
Probucol prevents atrial remodeling and suppresses atrial fibrillation development in a diabetic rabbit model by inhibiting oxidative stress and inflammatory pathways.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for probucol in diabetic AF; leaves open human translation pending trials.
Probucol prevents atrial remodeling and suppresses AF development in alloxan-induced diabetic rabbits. Its inhibitory effects on oxidative stress, NF-κB, TGF-β, and TNF-α overexpression may contribute to its antiremodeling effects.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: